QuotedData

Quoted Data

sign up for emailed equity research
Quick  |   Customised Register
Latest News

Biotech and Healthcare News

Baillie Gifford-favourite Alnylam completes key US filing

Baillie Gifford-favourite Alnylam completes key US filing

Baillie Gifford-favourite Alnylam completes key US filing US biotech star and Baillie Gifford stock pick Alnylam Pharmaceuticals has completed its US regulatory application for patisiran, a treatment of adults with hereditary ...

UK CAR-T firm Autolus provides update at ASH conference

UK CAR-T firm Autolus provides update at ASH conference

UK CAR-T firm Autolus provides update at ASH conference Autolus, a closely-watched chimeric antigen receptor T-cell therapy firm backed by three of the UK's most prominent biotech investors, obtained an important ...

Gilead reassures with CAR-T therapy durability data

Gilead reassures with CAR-T therapy durability data

Gilead reassures with CAR-T therapy durability data - Leading US biotech and investment company favourite Gilead Sciences has reassured investors with an important clinical trial update for its high profile cancer therapy ...

Scottish Mortgage to benefit from Denali IPO

Scottish Mortgage to benefit from Denali IPO

Scottish Mortgage to benefit from Denali IPO - Baillie Gifford-managed Scottish Mortgage Investment Trust SMT looks set to receive a significant £85m windfall as a result of last week's Nasdaq IPO of  ...

BioPharma Credit acquires royalty interest in diabetes drugs

BioPharma Credit acquires royalty interest in diabetes drugs

BioPharma Credit acquires royalty interest in diabetes drugs - In its third deal announced in rapid succession, BioPharma Credit has purchased from Royalty Pharma Investments (RPI) a 50% interest in a former Bristol-Myers ...

Alexion stock rises on reports of activist investor

Alexion stock rises on reports of activist investor

Alexion stock rises on reports of activist investor Stock in the US rare disease specialist Alexion Pharmaceuticals is up 6% this morning on reports that the famed New York-based activist hedge ...

Gilead acquires Cell Design Labs to bolster CAR-T presence

Gilead acquires Cell Design Labs to bolster CAR-T presence

Gilead acquires Cell Design Labs to bolster CAR-T presence Leading US biotech Gilead Sciences is to acquire privately-held Cell Design Labs in a structured buy out valued at to $567m, including ...

Isaly steps down from OrbiMed and Worldwide Healthcare Trust

Isaly steps down from OrbiMed and Worldwide Healthcare Trust

Isaly steps down from OrbiMed and Worldwide Healthcare Trust Veteran US biotech analyst and OrbiMed Capital founder Samuel Isaly has stepped down from his role as Managing Partner and separately as a ...

FDA OK for Alexion's Soliris in myasthenia gravis

FDA OK for Alexion’s Soliris in myasthenia gravis

FDA OK for Alexion's Soliris in myasthenia gravis US approval for Alexion's complement inhibitor Soliris in anti-acetylcholine receptor antibody-positive generalised myasthenia gravis could double the market for a product that is ...

Biotech Growth manager denies allegations

Biotech Growth manager denies allegations

Biotech Growth manager denies allegations - The board of The Biotech Growth Trust says that it notes that the General Partners of OrbiMed Capital LLC, which acts as portfolio manager to ...

Contact us

captcha